品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 | R022552-5g | 5g | 现货 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
罗恩 | R022552-250mg | 250mg | 现货 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
罗恩 | R022552-1g | 1g | 现货 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
罗恩 | R022552-5mg | 5mg | 5~7个工作日 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
罗恩 | R022552-50mg | 50mg | 5~7个工作日 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
罗恩 | R022552-25g | 25g | 5~7个工作日 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
阿拉丁 | S589153-250mg | 250mg | 期货,请咨询 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
≥97% |
|
|
阿拉丁 | S589153-100mg | 100mg | 期货,请咨询 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
≥97% |
|
|
阿拉丁 | S589153-1g | 1g | 期货,请咨询 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
≥97% |
|
|
阿拉丁 | S589153-5g | 5g | 期货,请咨询 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
≥97% |
|
|
韶远 | SY101981-5g | 5g | 现货 | 446292-10-0 |
(S)-4-[4-[2-氧代-5-(氨甲基)-3-噁唑烷... (S)-4-[4-[5-(Aminomethyl)-2-... |
≥95% |
|
|
毕得 | BD211760-1g | 1g | 现货 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
毕得 | BD211760-5g | 5g | 现货 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
毕得 | BD211760-250mg | 250mg | 现货 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
毕得 | BD211760-100mg | 100mg | 现货 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|
毕得 | BD211760-25g | 25g | 现货 | 446292-10-0 |
(S)-4-(4-(5-(氨基甲基)-2-氧代恶唑烷-3... (S)-4-(4-(5-(Aminomethyl)-2-... |
97% |
|
|